European Companies Search Engine

EU funding (€9,280,000): Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment Hor 1 Nov 2020 EU Research and Innovation programme "Horizon"

Text

Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment

The Gravitate-Health mission is to equip and empower citizens with digital information tools that make them confident, active, and responsive in their patient journey, specifically encouraging safe use of medicines for better health outcomes and quality of life. It is our vision that engagement of citizens in their own health can only be achieved with access to actionable, understandable, relevant, reliable and evidence-based information that meets their specific needs, health context, and literacy level. This project's ambition is to provide a key piece to advance this vision: the Gravitate Lens (G-lens), which focuses (but does not conceal or filter) approved electronic product information (ePI) content, and offers a route for patients to access trustworthy, up-to-date information that better meet their individual needs. Gravitate-Health is an integrated digital health information project. The principle objective is to demonstrate how use of an integrated, digital, user-centric health information solution with two-way communication could enable tangible improvements in availability and understanding of health information from a set of trusted sources, starting with regulator-approved medicinal product information (e.g. package leaflet content) and EHR-IPS (International Patient Summary). The secondary objectives are to demonstrate that the improved availability and understanding of health information from trusted sources translate to higher levels of adherence to treatment, safer use of medication (Pharmacovigilance), better health outcomes and quality of life, and to develop new and deeper insights into how use of available health information can be optimized to act as effective risk minimization measures. The project allows for efficient and timely development of the G-lens, provides testing grounds for new services and an evaluation framework to test the efficiency, efficacy and safety of Gravitate-Health services. Our main outputs will be an open source digital platform supporting G-lens functionally, demonstrated in a number of testing scenarios, and a White Paper with recommendations on realistic strategies to strengthen access, understanding and future use of digital services like ePIs as a tool for Risk Minimization. The Gravitate-Health is a public – private partnership with 45 members from Europe and the US, co-led by University of Oslo (coordinator) and Pfizer (industry lead), funded by the Innovative Medicines Initiative (IMI) – a joint undertaking of the European Commission, the European Federation of Pharmaceutical Industries and Associations (EFPIA), IMI Associated Partners.


Funded Companies:

Company name Funding amount
Agencia Espanola de Medicamentos y Productos Sanitarios €70,000
Agentschap College TER Beoordeling Van Geneesmiddelen €197,375
Akershus Universitetssykehus HF €344,375
Astrazeneca AB €0.00
Bayer AG €0.00
Beth Israel Deaconess Medical Center, INC NON Profit Corporation €0.00
Datapharm Ltd. €0.00
Datawizard Srl €402,313
Direktoratet FOR Medisinske Produkter €1,325.18
DLI - Dansk Laegemiddel Information A/S €22,501
Echalliance CLG €286,500
Eli Lilly and Company Ltd. €0.00
Empirica Gesellschaft FUR Kommunikations UND Technologieforschung mbH €534,554
F. Hoffmann-LA Roche AG €0.00
Felleskatalogen AS €33,751
Forum des Patients Europeens €302,725
Frisq Holding AB €106,838
Grunenthal GmbH €0.00
Guardtime OÜ €117,656
Himss Europe GmbH €268,375
HL7 Europe €729,429
Janssen Pharmaceutica N.V. €0.00
Karolinska Institutet €367,466
Kobenhavns Universitet €126,250
Lakemedelsindustriforeningens Service AB €22,501
Mdsol Europe Ltd. €0.00
Mindview Symvouloi Epixeiriseon Kaierevnas Etaireia Periorismenis Efthynis €149,625
Mylan IRE Healthcare Ltd. €0.00
Norsk E Helse AS €296,250
Novartis Pharma AG €0.00
Open Evidence €61,107
Oslo Universitetssykehus HF €155,000
Pfizer Ltd. €0.00
Pharmaca Health Intelligence Oy €22,501
Predictby Research And Consulting SL €296,345
Servicio Madrileno de Salud €142,481
SPMS - Servicos Partilhados do Ministerio da Saude ΕΠΕ €141,000
Synergist Services €0.00
THE European Institute for Innovation Through Health Data €273,304
The Provost, Fellows Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near Dublin €336,491
THE Synergist €249,000
Trifork Digital Health AS €431,407
UCB Biopharma €0.00
Universidad Politecnica de Madrid €609,554
Universita Cattolica Del Sacro Cuore €151,813
Universitetet I Oslo €1,860,565
Universitetssykehuset Nord-Norge HF €163,750
University College Dublin, National University of Ireland, Dublin €5,875.00

Source: https://cordis.europa.eu/project/id/945334

The filing refers to a past date, and does not necessarily reflect the current state.